AbbVie Inc. reports $15 billion revenue for quarter ended March 31, 2026, up 12.4%
AbbVie Inc. reported revenue of $15 billion for the quarter ended March 31, 2026, an increase of 12.4% from the same quarter a year earlier ($13.34 billion).
For the same period it posted net income of $695 million, down 46%, or $0.39 per diluted share (0.72 a year earlier).
That is a net margin of 4.6%.
On Sanad's AAOIFI Standard 21 screen, AbbVie Inc. is currently compliant: interest-bearing debt is 15.6% of market capitalisation (limit 30%), and impure income is 0.4% of revenue (limit 5%).
Is AbbVie Inc. halal?
See the full AAOIFI screening of AbbVie Inc.
See the full AAOIFI screening of AbbVie Inc.
Source: 10-Q filed with the U.S. Securities and Exchange Commission on May 8, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.